Clinical Trials on Hairy Cell Leukemia in Netherlands

Total 1550 results

University Medical Center Groningen

Completed

The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors

Neuroendocrine Tumors

Netherlands
University Medical Center Groningen
Novartis Pharmaceuticals

Completed

89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors (NETPET)

Neuroendocrine Tumors

Netherlands
Radboud University Medical Center

Completed

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Renal Cell Carcinoma | GIST

Netherlands
University of Zurich

Completed

Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients

Hematopoietic Stem Cell Transplantation

Switzerland, Netherlands
Amphia Hospital
Erasmus Medical Center

Terminated

The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy (CARACTER)

Small Cell Lung Cancer | Non Small Cell Lung Cancer

Netherlands
Amsterdam UMC, location VUmc
Foundation for the National Institutes of Health

Not yet recruiting

Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer (iRelate)

NSCLC

Netherlands
University Medical Center Groningen

Completed

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

Neuroendocrine Tumor

Netherlands
University Medical Center Groningen

Completed

Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study (VIDEO-NET)

Neuroendocrine Tumor

Netherlands
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Completed

Phenoxybenzamine Versus Doxazosin in PCC Patients (PRESCRIPT)

Pheochromocytoma

Netherlands
Academisch Ziekenhuis Maastricht
The Netherlands Cancer Institute; ZonMw: The Netherlands Organisation for Health...

Completed

Pharmacokinetic Boosting of Osimertinib (OSIBOOST)

Non Small Cell Lung Cancer

Netherlands
Boehringer Ingelheim

Completed

Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)

Leukemia, Myeloid, Acute

Korea, Republic of, Spain, Canada, Germany, Norway, Taiwan, Belgium, United States, Japan, Mexico, France, Greece, Italy, India, Austria, Portugal, Czechia, Russian Federation, Hungary, Brazil, Argentina, Finland, Netherlands, Poland, South...
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease (TROS)

Sickle Cell Disease

Netherlands
Radboud University Medical Center

Recruiting

Exendin PET/CT for Imaging of Paragangliomas (ENTRAP)

Paraganglioma

Netherlands
Daiichi Sankyo, Inc.

Completed

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

AML

United States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
University Medical Center Groningen

Completed

Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors

Melanoma | Non Small Cell Lung Cancer

Netherlands
M. Labots

Terminated

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

Renal Cell Cancer

Netherlands
Leiden University Medical Center

Terminated

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) (HR-GCT)

Giant Cell Tumor of Bone | Osteoclastoma

Netherlands, Belgium
The Netherlands Cancer Institute
4SC AG

Active, not recruiting

Pre-operative Immunotherapy in Stage II-III Urothelial Cancer (TURANDOT)

Urothelial Carcinoma

Netherlands
University Medical Center Groningen

Recruiting

POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors (POINTING)

Melanoma | Non-Small Cell Lung Cancer

Netherlands
Leiden University Medical Center
Jessa Hospital; The Netherlands Cancer Institute

Recruiting

Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy (Prediction)

Immunotherapy | Non Small Cell Lung Cancer Stage III

Netherlands, Belgium
Bristol-Myers Squibb
Innovative Therapies For Children with Cancer Consortium

Completed

Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

Leukemia

Germany, United Kingdom, France, Austria, Italy, Netherlands
National Cancer Institute (NCI)

Completed

Analyses of Human Samples Collected in Clinical Trials

Leukemia, Myeloid | Neoplasm Metastasis | Prostate Cancer | Leukemia, Lymphoid

United States, Netherlands
University Medical Center Groningen

Completed

Optimal Feeding for NET Patients (DIVIT-pilot)

Neuroendocrine Tumor

Netherlands
Celgene

Completed

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States, Korea, Republic of, United Kingdom, Australia, Taiwan, Israel, Canada, Spain, China, Italy, Germany, Netherlands, Russian Federation, Belgium, France, Poland, Czechia, Austria
Millennium Pharmaceuticals, Inc.

Completed

An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic

United States, Israel, Spain, France, Ireland, Canada, Germany, Czechia, Italy, Netherlands, Belgium, Bulgaria
Radboud University Medical Center

Completed

Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients

Melanoma

Netherlands
Astex Pharmaceuticals, Inc.

Completed

SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction

Leukemia, Myeloid, Acute

United States, Spain, Korea, Republic of, Taiwan, Australia, Canada, Denmark, Hungary, Japan, Finland, Italy, Serbia, Czechia, France, Germany, Sweden, Netherlands, Poland, Russian Federation, Austria, United Kingdom, Romania, Belgium, Bulgar...
Free University Medical Center

Unknown

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Netherlands
Jeroen Bosch Ziekenhuis

Unknown

Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer (DOCAR)

Small Cell Lung Cancer

Netherlands
University Medical Center Groningen

Unknown

Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Leukemia

Netherlands, Belgium, Switzerland
University Medical Center Groningen

Active, not recruiting

Image Guided Surgery in Sinonasal Inverted Papilloma (SNIPER)

Inverted Papilloma | Molecular Fluorescence Imaging

Netherlands
The Netherlands Cancer Institute
4SC

Active, not recruiting

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (DONIMI)

Malignant Melanoma Stage III

Netherlands
Amsterdam UMC, location VUmc

Completed

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | Brain Metastases

Netherlands
UMC Utrecht

Completed

Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study (HEPAR_Plus)

Neuroendocrine Tumors

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell Carcinoma (CUDI-RCC)

Kidney Cancer

Netherlands
LLS PedAL Initiative, LLC
AbbVie; Roche-Genentech; Princess Maxima Center for Pediatric Oncology (European... and other collaborators

Recruiting

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States, Canada, Denmark, Spain, Belgium, Australia, France, New Zealand, Netherlands, Czechia, Norway, Switzerland, Austria, Portugal, Italy, Sweden, Israel, Finland
Novartis Pharmaceuticals

Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Myeloid Leukemia, Philadelphia Positive

Korea, Republic of, Germany, France, Greece, Hungary, Italy, Japan, Russian Federation, Thailand, Turkey, China, United States, Netherlands, Poland
A.J.M. van den Eertwegh
Idera Pharmaceuticals, Inc.

Recruiting

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma (INTRIM)

Malignant Melanoma

Netherlands
Leiden University Medical Center

Recruiting

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Urothelial Carcinoma | Sarcoma,Soft Tissue

Netherlands
The Netherlands Cancer Institute

Recruiting

FMT to Convert Response to Immunotherapy

Melanoma Stage IV | Melanoma Stage III

Netherlands
Actuate Therapeutics Inc.

Active, not recruiting

9-ING-41 in Patients With Advanced Cancers

Sarcoma | Cancer | Breast Neoplasms | Neoplasm Metastasis | Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Bone Cancer | Malignant Glioma | Bone Metastases | Pancreas Cancer | Renal Cancer | Refractory Non-Hodgkin Lymphoma | Bone Neoplasm | Neoplasm, Breast | Refractory Cancer | Refractory Neoplasm | Resistant... and other conditions

United States, Belgium, Canada, Spain, France, Netherlands, Portugal
The Netherlands Cancer Institute
Merck Sharp & Dohme LLC

Completed

Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC (PEMBRO-RT)

Non-Small Cell Lung Cancer

Netherlands
Radboud University Medical Center

Completed

MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma (EMITT)

Glioblastoma

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center

Completed

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

Glioblastoma

Netherlands
Eli Lilly and Company

Terminated

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Small Cell Lung Cancer | SCLC | Carcinoma, Small Cell

Netherlands, Belgium
Maastricht University Medical Center

Unknown

Everolimus TDM to Predict Long Term Toxicity (Foresight)

Renal Cell Carcinoma | Breast Cancer | Neuroendocrine Neoplasm of Lung | Pancreatic Neuroendocrine Tumour | Gastrointestinal Neuroendocrine Tumour

Netherlands
University Medical Center Groningen

Withdrawn

89Zr-RO5323441 PET Imaging in Glioblastoma

Glioblastoma

Netherlands
Radboud University Medical Center
Dutch Cancer Society

Completed

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Hypertension | Insulin Sensitivity | Renal Function

Netherlands
Amsterdam UMC, location VUmc
National Research Council, Institute of Biomedical Engineering

Completed

PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide (PREDEX)

Glucocorticoid-induced Glucometabolic Abnormalities | Glucocorticoid-induced Beta-cell Dysfunction

Netherlands
Maastricht University
Radboud University Medical Center; University of California, San Francisco

Unknown

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

Nonsmall Cell Lung Cancer

Netherlands

Clinical Trials on Hairy Cell Leukemia in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations